The need for a quality control of the whole process of immunohistochemistry human epidermal growth factor receptor 2/neu determination: a United Kingdom National External Quality Assessment Service/Italian Network for Quality Assessment of Tumor Biomarkers pilot experience.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Volumn 25, Issue 22, 2007, Pages

  Paradiso, Angelo ^a   Miller, Keith ^a   Marubini, Ettore ^a   Pizzamiglio, Sara ^a   Verderio, Paolo ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; TRASTUZUMAB; TUMOR MARKER;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; ITALY; LABORATORY; NOTE; PATHOLOGY; PATIENT SELECTION; PILOT STUDY; PREDICTION AND FORECASTING; PROTO ONCOGENE; QUALITY CONTROL; REPRODUCIBILITY; STANDARD; UNITED KINGDOM;

ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; GENES, ERBB-2; GREAT BRITAIN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; ITALY; LABORATORIES; PATIENT SELECTION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 34548588536     PISSN: None     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.5155     Document Type: Note

References (0)